Genotoxicity and Cytotoxicity of novel 10B carrier ((2R)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)boronic acid
Journal Title: Medical Science and Discovery - Year 2014, Vol 1, Issue 4
Abstract
Objective: Although surgery and chemotherapy have been greatly successful in the treatment of many types of tumors, these treatment modalities have some limitations. In particular, the side effects of conventional radiotherapy warrant the development of new therapy methods, such as Boron Neutron Capture Therapy (BNCT). In the present study, the cytotoxic and genotoxic properties of novel synthesized boron carrier, ((2R)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)boronic acid (10BDG), and the apoptotic pathways triggered by 10BDG were examined. Material and Methods: As it defined previously, 10BDG was complexed through a low-high pH reaction and was tested using a Fournier Transform InfraRed-Attenuated Total Reflectance (FT-IR/ATR) spectrophotometer. The cytotoxicity of 10BDG was tested through the MTT assay. The detection of caspases 3, 8, and 9 was performed to determine the activated apoptotic pathways by 10BDG. The Poly (ADP-Ribose) Polymerase (PARP) cleavage and DNA damage induced by this compound were tested through western blot and Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, respectively. Results: The average LogIC50 and LogLD50 levels of 10BDG over NCI-H209 cell line were to be found 72.1±10 ug/ml and 171.8±25 mg/kg, respectively. Caspase-9 activation, caspase-3 activation, PARP cleavage, and caspase-3-dependent DNA fragmentation were observed. The genotoxicity analysis was performed using the plasmid fragmentation assay, which revealed the absence of fragmentation. Conclusion: Bio-distrubition analysis showed that boron content was elevated to 12.63 from 4.44 ppm in the tumor tissue by the 10BDG injections. In epitome, 10BDG exhibit slight cytotoxic but no genotoxic properties. Based on the antiproliferative properties of 10BDG, in addition to acting as an adjuvant in cancer radiotherapy and chemotherapy, this compound appears to be an alternative boron carrier for BNCT
Authors and Affiliations
Zafer Akan, Hulya Ozdemir, Gokhan Oto, Sabahattin Deniz, Omer Kacar, Ali Sadi Basak, Tahir Cakir, Hatice Uslu Sinav, Goksel Demir
Keywords
Related Articles
- EP ID EP520346
- DOI -
- Views 44
- Downloads 0
The effects of acupuncture on nausea and vomiting and consumption of propofol in cesarean section performed with spinal anesthesia
Objective: The incidence of hypotension is 50-60% in obstetric surgeries. The most frequent comorbid clinical case of hypotention is nausea and vomiting. In addition, the probability of vomiting and nausea is very high i...
Factors affecting the burden on caregivers of stroke survivors in Turkey
Purpose: Caring for stroke patients leads to caregiver strain. Caregiver burden following stroke is increasingly recognised as a significant health care concern. This study was conducted to determine factors affecting t...
Epidural blood patch for the treatment of post dural puncture headache in pregnant women
Objective: Postdural puncture headache (PDPH) is still a considerable problem and it is one of the most common complications of neuro axial anesthesia. Efficiency of the blood patch performed for the patients...
Evaluation of factors that affecting mortality in urgent redo-laparotomies
Objective: The aim of this study was to investigate the factors that affect mortality in patients undergoing Urgent abdominal redo-laparatomies (UARLs) and to analyze the common indications and operative,demograhic and c...
Cyberknife re-irradiation for recurrent glioblastoma multiforme
Objective: Treatment of patients with recurrent glioblastoma multiforme (GBM) is challenging. Treatment alternatives include re-operation, chemotherapy and re-irridation. Stereotactic radiosurgery with cyberkn...